BMGL vs RGNT

The Advanced Deterministic Scorecard reveals a critically weak financial health profile with a Piotroski F-Score of just 2/9, indicating severe operational and profitability concerns. Despite a positive revenue growth of 32.20% YoY and a gross margin of 26.29%, the company suffers from catastrophic profitability metrics including a -99.84% profit margin and -194.56% ROE, which undermine sustainable growth. Valuation multiples like Price/Book of 3.96 appear high given the lack of earnings and cash flow visibility, while the stock has lost over 80% of its value in the past year. The absence of Altman Z-Score and intrinsic value estimates further reflects data insufficiency and elevated distress risk.

RGNT exhibits severe financial distress characterized by a weak Piotroski F-Score of 3/9 and a complete absence of revenue. The company's ROA of -107.53% indicates massive capital erosion, while the stock price has collapsed by 61.7% over the last year. Despite a decent current ratio of 2.65, the lack of operational viability and a 0/100 technical trend suggest a high-risk speculative profile. The single analyst target of $10.00 is disconnected from the current fundamental reality.